Pilot Study of a Dual Gene Recombinant Avipox Vaccine Containing Both Carcinoembryonic Antigen (CEA) and B7.1 Transgenes in Patients with Recurrent CEA-expressing Adenocarcinoma

Reviewer: Ryan P. Smith, MD
The Abramson Cancer Center of the University of Pennsylvania
Ultima Vez Modificado: 4 de julio del 2004

Translation for this article does not exist


7 Tips for Giving Smart on #givingtuesday
by Christina Bach, MSW, LCSW, OSW-C
November 25, 2015

Related News

AACR: Peptide Vaccine Tested in Children With Gliomas

Apr 4, 2012

Glioma-associated antigen epitope vaccine shows evidence of immunological and clinical activity

Inhibition of Immune Pathway May Trigger Melanoma Growth

Apr 3, 2012

Colocalization of immune inhibitory B7-H1 and tumor-infiltrating lymphocytes seen in melanocytes

Prostate Cancer Vaccine Elicits Immune Response

Nov 30, 2015

Phase I/IIa clincial trial results suggest vaccine is safe and biologically active